InterCure
INCR | NASDAQ
$3.63
-$0.16 (-4.22%)
At close: Nov 16, 2026, 4:00 PM ET
$3.64
+$0.01 (+0.28%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-4.22%
(1D)No price chart data available for 1D timeframe.
Rating
30.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #782/1021 (Top 77%)
Key Statistics
Market Data
Market Cap $47.09M
1D Range
3.63 3.79
52W Range
3.30 7.25
Valuation (TTM)
PE -3.51
PB 0.38
EV/EBITDA -5.42
Valuation (NTM)
Forward PE N/A
Forward PEG -0.05
Price Target $0.00
Cash Flow
FCF Yield 16.0%
SBC Adj. FCF Yield 14.9%
SBC Impact -6.8%
Margins
Gross Margin 10.0%
Operating Margin -10.1%
FCF Margin 9.0%
Growth (CAGR)
Revenue 3Y | 5Y -11.4% |
33.0%
Dil EPS 3Y | 5Y 27.9% |
-75.9%
FCF 3Y | 5Y -8.2% |
-83.1%
Returns
ROA -5.0%
ROE -8.5%
ROIC -5.2%
Financial Health
Net Debt
₪112.59M ($35.5M)
Current Ratio 1.48
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturin...
Sector Healthcare
Employees 285
IPO Date Jan 28, 2019
Website www.intercure.co
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove INCR